Kuros Biosciences AG (SWX:KURN)
21.40
-0.52 (-2.37%)
Apr 29, 2026, 3:13 PM CET
Kuros Biosciences AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 859 | 1,076 | 806 | 128 | 54 | 63 | Upgrade
|
| Market Cap Growth | 25.39% | 33.55% | 528.00% | 138.81% | -14.90% | -4.70% | Upgrade
|
| Enterprise Value | 844 | 1,063 | 793 | 114 | 34 | 38 | Upgrade
|
| Last Close Price | 21.92 | 27.48 | 21.35 | 3.49 | 1.47 | 1.93 | Upgrade
|
| PE Ratio | 424.52 | 531.92 | - | - | - | - | Upgrade
|
| PS Ratio | 7.41 | 9.29 | 10.44 | 3.82 | 2.99 | 4.57 | Upgrade
|
| PB Ratio | 12.82 | 16.06 | 13.80 | 2.26 | 0.78 | 0.82 | Upgrade
|
| P/TBV Ratio | 24.84 | 31.13 | 33.33 | 8.15 | 2.67 | 3.01 | Upgrade
|
| P/FCF Ratio | - | - | 385.54 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 251.14 | - | - | - | Upgrade
|
| EV/Sales Ratio | 7.29 | 9.18 | 10.28 | 3.41 | 1.90 | 2.77 | Upgrade
|
| EV/EBITDA Ratio | 86.49 | 116.34 | 377.84 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 118.96 | 149.76 | 7295.50 | - | - | - | Upgrade
|
| EV/FCF Ratio | -367.85 | - | 379.64 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.11 | 0.11 | 0.64 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 0.85 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.22 | -0.22 | -0.28 | -0.21 | -0.32 | -0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.59 | -1.59 | -7.68 | 4.04 | 2.95 | 4.17 | Upgrade
|
| Net Debt / FCF Ratio | 6.35 | 6.35 | -7.72 | 1.32 | 2.86 | 4.58 | Upgrade
|
| Asset Turnover | 1.29 | 1.29 | 0.99 | 0.44 | 0.21 | 0.15 | Upgrade
|
| Inventory Turnover | 1.17 | 1.17 | 1.21 | 1.27 | 1.47 | 2.33 | Upgrade
|
| Quick Ratio | 1.42 | 1.42 | 1.64 | 2.22 | 2.20 | 2.72 | Upgrade
|
| Current Ratio | 1.96 | 1.96 | 2.14 | 2.77 | 2.49 | 2.91 | Upgrade
|
| Return on Equity (ROE) | 3.31% | 3.31% | -6.59% | -16.18% | -20.02% | -9.33% | Upgrade
|
| Return on Assets (ROA) | 4.94% | 4.94% | 0.09% | -4.12% | -7.06% | -5.90% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.65% | 7.80% | 0.24% | -11.67% | -20.09% | -15.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.80% | 9.80% | 0.20% | -8.20% | -14.00% | -11.00% | Upgrade
|
| Earnings Yield | 0.24% | 0.19% | -0.54% | -10.70% | -27.17% | -11.95% | Upgrade
|
| FCF Yield | -0.27% | -0.21% | 0.26% | -7.14% | -14.41% | -9.13% | Upgrade
|
| Buyback Yield / Dilution | -11.26% | -11.26% | -1.69% | -7.91% | -3.37% | -34.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.